Vanda Pharmaceuticals, Inc. (VNDA)
6.26
-0.02
(-0.32%)
USD |
NASDAQ |
May 18, 10:14
Vanda Pharmaceuticals Profit Margin (Quarterly) : -93.91% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AnaptysBio, Inc. | -206.9% |
| Amgen, Inc. | 21.02% |
| Gossamer Bio, Inc. | -275.2% |
| BridgeBio Pharma, Inc. | -85.63% |
| Geron Corp. | -7.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.81% |
| Return on Assets | -43.08% |
| Return on Invested Capital | -56.19% |
| Gross Profit Margin (Quarterly) | 90.05% |
| Operating Margin (Quarterly) | -97.11% |
| Return on Net Operating Assets | -133.7% |